Provided by Tiger Fintech (Singapore) Pte. Ltd.

UpStream Bio Inc.

9.61
+0.55006.07%
Post-market: 9.610.00000.00%17:18 EDT
Volume:134.43K
Turnover:1.26M
Market Cap:515.06M
PE:-0.40
High:9.62
Open:9.33
Low:9.03
Close:9.06
Loading ...

UWM delivers highest volume in three years amid mini refi boom

HousingWire
·
08 Nov 2024

BRIEF-Upstream Bio Reports Q3 2024 Financial Results And Recent Business Highlights

Reuters
·
07 Nov 2024

Upstream Bio Q3 Sales $607.00K Down From $621.00K YoY, Completed Upsized IPO With Gross Proceeds Of Approximately $293M, Extending Runway Through 2027

Benzinga
·
07 Nov 2024

Upstream Bio Inc: Qtrly Net Loss $16.0 Mln

THOMSON REUTERS
·
07 Nov 2024

JPMorgan Initiates Upstream Bio at Overweight With $38 Price Target

MT Newswires Live
·
05 Nov 2024

Piper Sanlder Initiates Upstream Bio at Overweight With $75 Price Target

MT Newswires Live
·
05 Nov 2024

William Blair Initiates Upstream Bio at Outperform

MT Newswires Live
·
05 Nov 2024

TD Cowen Initiates Upstream Bio at Buy

MT Newswires Live
·
05 Nov 2024

Upstream Bio Initiated at Overweight by Piper Sandler

Dow Jones
·
05 Nov 2024

Upstream Bio Inc : TD Cowen Initiates Coverage With Buy Rating

THOMSON REUTERS
·
05 Nov 2024

Promising Prospects for Upstream Bio’s Verekitug: A Potential Blockbuster in Inflammatory Disease Treatment

TIPRANKS
·
05 Nov 2024

Upstream Bio initiated with a Buy at TD Cowen

TIPRANKS
·
05 Nov 2024

Upstream Bio initiated with an Outperform at William Blair

TIPRANKS
·
05 Nov 2024

Catalyst Watch: Eyes on election bets, FOMC meeting, drug data, and NXP Semiconductors event

seekingalpha
·
02 Nov 2024

TWO Reports Third Quarter 2024 Financial Results

Business Wire
·
29 Oct 2024

AI Upstream Llc Reports 10.7% Stake in Upstream Bio Inc as of Oct 15 - SEC Filing

THOMSON REUTERS
·
23 Oct 2024